155 related articles for article (PubMed ID: 3460693)
1. Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis.
Johnson CS; Thurlow SM; Marcelletti JF; Furmanski P
Cancer Res; 1986 Aug; 46(8):3896-902. PubMed ID: 3460693
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of normal erythropoiesis in vitro by macrophages from erythroleukemic mice.
Johnson CS; Marcelletti J; Furmanski P
J Natl Cancer Inst; 1984 Feb; 72(2):491-6. PubMed ID: 6582332
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression.
Marcelletti J; Furmanski P
J Immunol; 1978 Jan; 120(1):1-8. PubMed ID: 203629
[TBL] [Abstract][Full Text] [Related]
4. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
5. Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor.
Furmanski P; Johnson CS
Blood; 1990 Jun; 75(12):2328-34. PubMed ID: 2350578
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system.
Johnson CS; Chang MJ; Thurlow SM; Pourbohloul SC; Furmanski P
Cancer Res; 1990 Sep; 50(17 Suppl):5682S-5686S. PubMed ID: 2117483
[TBL] [Abstract][Full Text] [Related]
7. Erythroid cell fusion in the early phase of Friend virus leukemogenesis.
Behringer RR; LoCascio NJ; Dewey MJ
J Natl Cancer Inst; 1987 Sep; 79(3):601-3. PubMed ID: 3476795
[TBL] [Abstract][Full Text] [Related]
8. Impaired macrophage function in Friend virus leukemia: restoration by statolon.
Levy MH; Wheelock EF
J Immunol; 1975 Mar; 114(3):962-5. PubMed ID: 1167568
[TBL] [Abstract][Full Text] [Related]
9. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Friend virus (FVP)-induced murine erythropoiesis with prostaglandin (PGF2 alpha): potentiation and inhibition of erythropoietin and prevention of both with PGD2.
Lewis JP; Moores RR; Neal WA; Garver FA; Lutcher CL; Zucali JR; Mirand EA
Exp Hematol; 1981 May; 9(5):540-9. PubMed ID: 6940758
[TBL] [Abstract][Full Text] [Related]
11. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice.
Fagg B; Ostertag W
J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173
[TBL] [Abstract][Full Text] [Related]
12. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
13. On the role of the spleen in Friend virus (F-MuLV-P) erythroleukemia.
Kreja L; Seidel HJ
Exp Hematol; 1985 Aug; 13(7):623-8. PubMed ID: 3861325
[TBL] [Abstract][Full Text] [Related]
14. [Nature of the target cells for Rauscher and Friend leukemia viruses].
Sanin AV; Khorobrykh VV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (8):5-20. PubMed ID: 6996749
[No Abstract] [Full Text] [Related]
15. Macrophage-induced reversal of immunosuppression by leukemia viruses.
Specter SC; Bendinelli M; Ceglowski WS; Friedman H
Fed Proc; 1978 Jan; 37(1):97-101. PubMed ID: 201505
[TBL] [Abstract][Full Text] [Related]
16. In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications.
Johnson CS; Chang MJ; Furmanski P
Blood; 1988 Dec; 72(6):1875-83. PubMed ID: 3196871
[TBL] [Abstract][Full Text] [Related]
17. Modification of erythropoiesis and hormone sensitivity by RNA tumor viruses.
Hankins WD; Kaminchik J
Prog Clin Biol Res; 1984; 148():141-52. PubMed ID: 6589645
[No Abstract] [Full Text] [Related]
18. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane.
Koury MJ; Bondurant MC; Atkinson JB
Blood Cells; 1987; 13(1-2):217-26. PubMed ID: 3478108
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the early and late stages of myelomonocytic leukemia induced by Friend helper-independent virus F-MuLV: isolation and induction of Friend myelomonocytic leukemic cell lines.
Shibuya T; Mak TW
J Cell Physiol; 1983 Dec; 117(3):283-9. PubMed ID: 6581171
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
Hsu KH; Friedman H
J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
